Alyeska Investment Group, L.P.

Holdings History for Applied Therapeutics, Inc. - Common Stock, par value $0.0001 per share (APLT)

Symbol: APLT on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 6,707,497 shares
Security Ownership %: 5.8%

Shares, Excluding Options vs Price

Value, Excluding Options

Alyeska Investment Group, L.P. ownership in Applied Therapeutics, Inc. Common Stock, par value $0.0001 per share (APLT)

14 Feb 2025 - Alyeska Investment Group, L.P. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,707,497 shares of Applied Therapeutics, Inc. Common Stock, par value $0.0001 per share (APLT). This represents 5.8% ownership of the company. This is the first filing by Alyeska Investment Group, L.P. disclosing ownership of Applied Therapeutics, Inc. Common Stock, par value $0.0001 per share (APLT).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Alyeska Investment Group, L.P.	5.8%		$2,146,399	6,707,497			$0.3200	13G	31 Dec 2024	14 Feb 2025, 16:30

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Jun 2025			-0.01%	$0	0	-3,107,497	-100%		Q2 2025
31 Mar 2025		0.01%	+0%	$1,519,255	3,107,497	+400,000		$0.4889	Q1 2025
31 Dec 2024		0.01%	+0.01%	$2,318,159	2,707,497	+1,725,824	+176%	$0.8562	Q4 2024
30 Sep 2024		0.04%	-0.04%	$8,344,221	981,673	-983,973	-50%	$8.50	Q3 2024
30 Jun 2024		0.05%	+0.02%	$9,179,567	1,965,646	+522,720	+36%	$4.67	Q2 2024
30 Jun 2024	call			$0	0	-4,000,000	-100%		Q2 2024
31 Mar 2024		0.06%	-0.05%	$9,774,297	1,442,926	-1,161,793	-45%	$6.77	Q1 2024
31 Mar 2024	call	12%	-0.16%	$27,200,000	4,000,000	-3,500,000	-47%	$6.80	Q1 2024
31 Dec 2023		0.06%	-0.04%	$8,725,809	2,604,719	-1,615,941	-38%	$3.35	Q4 2023
31 Dec 2023	call	0.17%	0%	$25,125,000	7,500,000	0		$3.35	Q4 2023
30 Sep 2023		0.07%	-0%	$10,509,443	4,220,660	-210,746	-4.8%	$2.49	Q3 2023
30 Sep 2023	call	0.13%	0%	$18,675,000	7,500,000	0		$2.49	Q3 2023
30 Jun 2023		0.04%	+0.03%	$5,672,200	4,431,406	+3,632,304	+455%	$1.28	Q2 2023
30 Jun 2023	call	0.07%	+0.03%	$9,600,000	7,500,000	+3,250,000	+76%	$1.28	Q2 2023
31 Mar 2023		0.01%	-0%	$648,152	799,102	-468,950	-37%	$0.8111	Q1 2023
31 Mar 2023	call	0.03%	+0.03%	$3,447,175	4,250,000	+4,250,000	NEW	$0.8111	Q1 2023
31 Dec 2022		0.01%	-0.02%	$963,720	1,268,052	-1,945,161	-61%	$0.7600	Q4 2022
31 Dec 2022	call		-0.05%	$0	0	-4,250,000	-100%		Q4 2022
30 Sep 2022		0.03%	-0.01%	$2,989,000	3,213,213	-1,144,477	-26%	$0.9302	Q3 2022
30 Sep 2022	call	0.05%	+0.05%	$3,953,000	4,250,000	+4,250,000	NEW	$0.9301	Q3 2022
30 Jun 2022		0.05%	+0.05%	$4,132,000	4,357,690	+4,357,690	NEW	$0.9482	Q2 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.